Boston Family Office LLC Novo Nordisk A S Transaction History

Boston Family Office LLC

$1.48 Billion
Q3 2024

A detailed history of Boston Family Office LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Boston Family Office LLC holds 44,524 shares of NVO stock, worth $3.78 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

44,524

Previous 43,244 2.96%

Holding current value

$3.78 Million

Previous $6.17 Million 14.13%

% of portfolio

0.36%

Previous 0.44%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $152,409 - $186,137	1,280 Added 2.96%	44,524 $5.3 Million
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $338,679 - $405,471	-2,760 Reduced 6.0%	43,244 $6.17 Million
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $310,005 - $412,653	-3,036 Reduced 6.19%	46,004 $5.91 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $2.23 Million - $4.89 Million	24,520 Added 100.0%	49,040 $4.46 Million
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $551,593 - $663,295	-4,168 Reduced 14.53%	24,520 $3.9 Million
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $394,554 - $484,207	-4,141 Reduced 12.61%	28,688 $2.86 Million
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $51,620 - $60,905	-500 Reduced 1.5%	32,829 $3.66 Million
Q1 2022 May 11, 2022	SELL	$93.1 - $112.54 $334,508 - $404,356	-3,593 Reduced 9.73%	33,329 $3.7 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $101,249 - $123,636	-1,056 Reduced 2.78%	36,922 $4.14 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $41,956 - $52,990	-497 Reduced 1.29%	37,978 $3.65 Million
Q3 2020 Nov 10, 2020	SELL	$63.69 - $70.22 $518,054 - $571,169	-8,134 Reduced 17.45%	38,475 $2.67 Million
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $117 - $135	-2 Reduced -0.0%	46,609 $3.05 Million
Q1 2020 May 11, 2020	SELL	$49.46 - $64.78 $17,607 - $23,061	-356 Reduced 0.76%	46,611 $2.81 Million
Q1 2019 May 09, 2019	SELL	$46.36 - $52.63 $18,636 - $21,157	-402 Reduced 0.85%	46,967 $2.46 Million
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $18,277 - $20,790	-440 Reduced 0.92%	47,369 $2.18 Million
Q4 2017 Feb 06, 2018	SELL	$47.53 - $53.73 $144,776 - $163,661	-3,046 Reduced 5.99%	47,809 $2.57 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $2.09 Million - $2.5 Million	50,855	50,855 $2.45 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Account

Boston Family Office LLC Novo Nordisk A S Transaction History